Jill Biden has 'rebound' COVID-19 case, president negative
First lady Jill Biden has tested positive for COVID-19 again in an apparent “rebound” case, after she initially tested negative for the virus over the weekend
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.First lady Jill Biden has tested positive for COVID-19 again in an apparent “rebound” case, after she initially tested negative for the virus over the weekend.
President Joe Biden, who spent three days with his wife at their Rehoboth Beach, Del. vacation home, continues to test negative, the White House said. He also suffered a rebound case earlier this month after an initial recovery from the virus.
Biden's deputy communications director Kelsey Donohue said she “has experienced no reemergence of symptoms, and will remain in Delaware where she has reinitiated isolation procedures.” She added: “The White House Medical Unit has conducted contact tracing and close contacts have been notified.”
Jill Biden, 71, had been prescribed the antiviral drug Paxlovid, which has proven to be highly effective at preventing serious disease and death among those at highest risk from COVID-19, but a minority of those prescribed the drug have experienced a rebound case of the virus a few days after their initial recovery.